Horizons Ventures and Sofinnova Partners Co-Lead Investment in Market-leading Life Sciences Software Company That Transforms the Way Scientists Automate Experimentation and Share Insights LONDON & BOSTON — Synthace, the first life sciences software company to enable scientists to automate biology experimentation and insight sharing in a unified, global R&D environment today announced it raised $35 […]
Funds will accelerate commercial activity and product development initiatives Durham, NC: Cell Microsystems Inc, a developer and manufacturer of innovative products for single cell workflows, announced the closing of a $10 million financing from Telegraph Hill Partners (“THP”), a life science venture capital and growth equity firm based in San Francisco, CA. The Company’s lead […]
Designed to bypass the oligo bottleneck in genomic research and development, the new platform will build on the success of DNA Script’s recently launched SYNTAX System using their innovative Enzymatic DNA Synthesis technology SOUTH SAN FRANCISCO, Calif., and PARIS — DNA Script, a leader in benchtop enzymatic DNA synthesis, today announced that the company has […]
NEW YORK — Accenture (NYSE: ACN) has made a strategic investment, through Accenture Ventures, in Geneyx Genomex Ltd. (Geneyx), an Israel-based developer of genomic analysis and interpretation software. Geneyx helps improve patient outcomes associated with hereditary and rare diseases by providing disease-specific, clinically relevant insights around risk prediction, diagnosis, prognosis, and treatment for clinical and pharmaceutical organizations. Today, […]
Qlucore AB (public) (“Qlucore” or “Company”) has today received approval of the application for listing of Qlucore shares on the Nasdaq First North Growth Market. The first day of trading of the shares will be 5th November 2021. Trading will be done with the ticker QCORE. “This paves the way for a new phase in […]
FORT LAUDERDALE, Fla. — Gemini Bioproducts, LLC (“GeminiBio”), a leading manufacturer of cell culture products and custom cGMP bioprocess liquids, announced today that it has secured financing from BroadOak Capital Partners, LLC (“BroadOak”), a boutique direct investment and advisory firm focused on life science research tools and diagnostics. The transaction with BroadOak provides GeminiBio additional […]
Funds to drive commercial expansion as growing number of facilities bring genomics into communities worldwide ST. LOUIS, MO — PierianDx, the global leader in clinical genomics knowledge, announced that it closed on $30 million of new growth capital including equity financing and a term loan facility, which includes access to additional tranches for up to […]
Technology increases the amount and quality of data that can be efficiently and cost-effectively obtained from a small DNA sample Manufacturing of the first product from a new technology platform is underway with expected commercial availability in early 2022; early access programs with renowned research institutions are ongoing CAMBRIDGE, United Kingdom — Cambridge Epigenetix (CEGX), […]
Cambridge, UK: Sphere Fluidics, a company that has developed and is commercialising single cell analysis systems underpinned by its proprietary picodroplet technology, announced today that it has closed a $40 million (circa £30 million) investment round. The round was led by Sofinnova Partners (Paris, France) and Redmile Group (San Francisco, USA) co-investing on equal terms. Sphere Fluidics […]
New Funding, Targeted to Accelerate Application Expansion and Platform Commercialization, Brings Total Amount Raised to Date to $280M SOUTH SAN FRANCISCO, Calif., and PARIS — DNA Script, a pioneer in Enzymatic DNA Synthesis (EDS) and DNA printing on demand, today announced it has raised $165 million in a Series C financing led by Coatue Management […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
